260 related articles for article (PubMed ID: 24736663)
1. The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.
Ruggeri P; Farina AR; Di Ianni N; Cappabianca L; Ragone M; Ianni G; Gulino A; Mackay AR
PLoS One; 2014; 9(4):e94568. PubMed ID: 24736663
[TBL] [Abstract][Full Text] [Related]
2. Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
Cappabianca L; Ruggieri M; Sebastiano M; Sbaffone M; Martelli I; Ruggeri P; Di Padova M; Farina AR; Mackay AR
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791513
[TBL] [Abstract][Full Text] [Related]
3. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Pellegrini C; Fargnoli MC; Mackay AR
J Exp Clin Cancer Res; 2018 Jun; 37(1):119. PubMed ID: 29914559
[TBL] [Abstract][Full Text] [Related]
5. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
[TBL] [Abstract][Full Text] [Related]
6. TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.
Farina AR; Di Ianni N; Cappabianca L; Ruggeri P; Ragone M; Ianni G; Gulino A; Mackay AR
Biomed Res Int; 2013; 2013():740187. PubMed ID: 23841091
[TBL] [Abstract][Full Text] [Related]
7. TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation.
Farina AR; Cappabianca L; Gneo L; Ruggeri P; Mackay AR
Oncotarget; 2018 Feb; 9(9):8368-8390. PubMed ID: 29492201
[TBL] [Abstract][Full Text] [Related]
8. Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Maccarone R; Mackay AR
Oncotarget; 2015 Nov; 6(34):35636-51. PubMed ID: 26415233
[TBL] [Abstract][Full Text] [Related]
9. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Desantis G; Tessitore A; Vetuschi A; Sferra R; Rucci N; Argenti B; Screpanti I; Gulino A; Mackay AR
Cancer Cell; 2004 Oct; 6(4):347-60. PubMed ID: 15488758
[TBL] [Abstract][Full Text] [Related]
10. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells.
Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
[TBL] [Abstract][Full Text] [Related]
12. The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
Cappabianca L; Zelli V; Pellegrini C; Sebastiano M; Maccarone R; Clementi M; Chiominto A; Ruggeri P; Cardelli L; Ruggieri M; Sbaffone M; Fargnoli MC; Guadagni S; Farina AR; Mackay AR
Cells; 2023 Jan; 12(2):. PubMed ID: 36672171
[TBL] [Abstract][Full Text] [Related]
13. Diclofenac-induced apoptosis in the neuroblastoma cell line SH-SY5Y: possible involvement of the mitochondrial superoxide dismutase.
Cecere F; Iuliano A; Albano F; Zappelli C; Castellano I; Grimaldi P; Masullo M; De Vendittis E; Ruocco MR
J Biomed Biotechnol; 2010; 2010():801726. PubMed ID: 20625417
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
15. TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importance.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Cell Cycle; 2005 Jan; 4(1):8-9. PubMed ID: 15611661
[TBL] [Abstract][Full Text] [Related]
16. Depletion of the Human Ion Channel TRPM2 in Neuroblastoma Demonstrates Its Key Role in Cell Survival through Modulation of Mitochondrial Reactive Oxygen Species and Bioenergetics.
Bao L; Chen SJ; Conrad K; Keefer K; Abraham T; Lee JP; Wang J; Zhang XQ; Hirschler-Laszkiewicz I; Wang HG; Dovat S; Gans B; Madesh M; Cheung JY; Miller BA
J Biol Chem; 2016 Nov; 291(47):24449-24464. PubMed ID: 27694440
[TBL] [Abstract][Full Text] [Related]
17. Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.
Cappabianca L; Farina AR; Di Marcotullio L; Infante P; De Simone D; Sebastiano M; Mackay AR
J Exp Clin Cancer Res; 2019 Dec; 38(1):482. PubMed ID: 31805994
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
20. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]